Back to Search Start Over

Dosimetric Impact of Acuros XB Dose-to-Water and Dose-to-Medium Reporting Modes on Lung Stereotactic Body Radiation Therapy and Its Dependency on Structure Composition.

Authors :
Muñoz-Montplet C
Fuentes-Raspall R
Jurado-Bruggeman D
Agramunt-Chaler S
Onsès-Segarra A
Buxó M
Source :
Advances in radiation oncology [Adv Radiat Oncol] 2021 May 19; Vol. 6 (4), pp. 100722. Date of Electronic Publication: 2021 May 19 (Print Publication: 2021).
Publication Year :
2021

Abstract

Purpose: Our purpose was to assess the dosimetric effect of switching from the analytical anisotropic algorithm (AAA) to Acuros XB (AXB), with dose-to-medium (Dm) and dose-to-water (Dw) reporting modes, in lung stereotactic body radiation therapy patients and determine whether planning-target-volume (PTV) dose prescriptions and organ-at-risk constraints should be modified under these circumstances.<br />Methods and Materials: We included 54 lung stereotactic body radiation therapy patients. We delineated the PTV, the ipsilateral lung, the contralateral lung, the heart, the spinal cord, the esophagus, the trachea, proximal bronchi, the ribs, and the great vessels. We performed dose calculations with AAA and AXB, then compared clinically relevant dose-volume parameters. Paired t tests were used to analyze differences of means. We propose a method, based on the composition of the involved structures, for predicting differences between AXB Dw and Dm calculations.<br />Results: The largest difference between the algorithms was 4%. Mean dose differences between AXB Dm and AXB Dw depended on the average composition of the volumes. Compared with AXB, AAA underestimated all PTV dose-volume parameters (-0.7 Gy to -0.1 Gy) except for gradient index, which was significantly higher (4%). It also underestimated V <subscript>5</subscript> of the contralateral lung (-0.3%). Significant differences in near-maximum doses (D <subscript>2</subscript> ) to the ribs were observed between AXB Dm and AAA (1.7%) and between AXB Dw and AAA (-1.6%). AAA-calculated D <subscript>2</subscript> was slightly higher in the remaining organs at risk.<br />Conclusions: Differences between AXB and AAA are below the threshold of clinical detectability (5%) for most patients. For a small subgroup, the difference in maximum doses to the ribs between AXB Dw and AXB Dm may be clinically significant. The differences in dose volume parameters between AXB Dw and AXB Dm can be predicted with reference to structure composition.<br /> (© 2021 The Authors.)

Details

Language :
English
ISSN :
2452-1094
Volume :
6
Issue :
4
Database :
MEDLINE
Journal :
Advances in radiation oncology
Publication Type :
Academic Journal
Accession number :
34258473
Full Text :
https://doi.org/10.1016/j.adro.2021.100722